n (males) | 509 |
---|---|
Age, years | 54±10 (30–100) |
Body mass index (BMI), kg/m2 | 24.1±3.0 (14.8−36.5) |
Hypertension, % (medication, %) | 42.2 (23.8) |
Systolic blood pressure (SBP), mmHg | 123±12 (91–174) |
Diastolic blood pressure (DBP), mmHg | 78±8 (47–100) |
Diabetes, % (medication, %) | 33.6 (4.9) |
Fasting blood glucose (FBG), mg/dL | 109±18 (64–284) |
Hemoglobin A1c (HbA1c), (NGSP), % | 5.8±0.6 (4.5−10.2) |
Estimated glomerular filtration rate (eGFR), mL/min | 69.4±12.8 (28.6−130.5) |
Dyslipidemia, % (medication, %) | 40.9 (12.4) |
Total cholesterol (T-cho), mg/dL | 204±33 (104–332) |
Triglyceride (TG), mg/dL | 140±94 (35–871) |
High-density lipoprotein-cholesterol (HDL-C), mg/dL | 56±13 (27–97) |
History of myocardial infarction, angina, stroke, heart failure, and renal failure, % | 0.8/0.2/0.6/0.6/23.8 |
Smoking (none-/ex--/current-), % | 26.2/48.0/25.8 |
Brinkman index | 383±352 (0–2000) |
Serum Total-APN, μg/mL | 6.8±3.6 (1.1−34.8) |
Serum HMW-APN, μg/mL | 4.9±3.6 (0.2−32.3) |
Serum C1q-APN, units/mL | 67.8±19.8 (31.6−209.3) |
Serum C1q, μg/mL | 56.7±9.8 (17.3−84.2) |
Serum HWM-APN/Total-APN ratio | 0.7±0.2 (0.2−1.3) |
Serum C1q-APN/Total-APN ratio | 11.5±4.6 (2.6−44.3) |
Serum C1q-APN/HMW-APN ratio | 20.4±17.0 (2.8−225.3) |
Serum C1q-APN/C1q ratio | 1.2±0.5 (0.5−4.0) |